![](https://investorshub.advfn.com/uicon/179008.png?cb=1517117993)
Sunday, September 09, 2018 10:24:02 AM
FINS COST NOTHING HE COULD HAVE EASILY POSTED THEM AND STOCK GOES UP SO WHY NOT?
COMMON SENSE SAYS THERE ARE THINGS IN THE FILINGS THAT COULD CAUSE THE PPS TO RISE AND LET THE CAT OUTTA THE BAG BEFORE ITS TIME PLAIN AND SIMPLE!
UNIVEC IMO HAS MORE THAN MOST THINK OR KNOW HERE I HAVE READ PAST FILINGS AND THERE IS MORE THAN MEETS THE EYE!
![wink](/images/emoticon03.gif)
$UNVC/AGRIMED/SATIVEO/HCI to .50plus
UNIVEC Announces FDA Labeler Code Approval
Baltimore, MD, August 09, 2011 --(PR.com)-- UNIVEC announces FDA approval of Labeler Code.
Univec, Inc. (UNVC) a specialty pharmaceutical company, announces it has been issued a FDA labeler code. This is the prefix for each National Drug Code (NDC) on products that is manufactured and distributed by Univec for the company’s Specialty Pharmaceuticals. The National Drug Code is a unique identifier assigned by the FDA to identify the manufacturer of a prescription drug product intended for human use. The NDC number is also used in the electronic claim processing for payment by third party entities and e-prescribing for physicians.
David L. Dalton, President and CEO of Univec stated, "We are delighted to make progress in our new business model. The National Drug Codes are very important not only from the standpoint of the FDA, but it also allows payment from Medicare, Medicaid, Insurance companies and other third party payment systems. This is another milestone reached in placement of a solid foundation to build and grow the company. We thank our associates, shareholders and investors for the support and confidence they have shown the company."
About Univec
Univec, Inc.
A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes high cost Specialty Pharmaceuticals. Specialty Pharmaceuticals are high cost products that are not usually dispensed in retail pharmacies but require special handling and a complex pharmaceutical regime. The company is focused on diseases such as Sickle Cell Anemia, Cancer, HIV/Aids, Hepatitis C., Multiple Sclerosis, Hemophilia and Drug addiction.
PPSI (Physician and Pharmaceutical Services, Inc.)
a subsidiary of Univec promotes and pays for pharmaceutical products though its network of pharmacies. PPSI eliminates the need for the pharmaceutical companies to distribute actual drug samples to physicians reducing potential liability for the physician while maintaining clinical oversight and drug interaction checks for the patient. The company through it’s "StarterScript" allows in lieu of a physician sample, a voucher or a co-payment card to be provide to the patient for a trial supply of medication redeemed in any of the nearly 55,000 retail pharmacies utilizing the PPSI real-time processing system.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM